Literature DB >> 12072633

Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma.

David Shibata1, Philip B Paty, Jose G Guillem, W Douglas Wong, Alfred M Cohen.   

Abstract

PURPOSE: Isolated locoregional disease accounts for approximately 20 percent of recurrences after treatment for colorectal cancer. It has been suggested that complete resection of these recurrences can result in increased survival. The value of surgery for isolated retroperitoneal recurrences has not been well defined. We have sought to characterize outcome and survival in patients undergoing resection for isolated retroperitoneal recurrences of colorectal cancer.
METHODS: From a prospective database, 25 patients were identified as having undergone surgical exploration with curative intent for isolated retroperitoneal recurrences of colorectal cancer between 1988 and 1999. Variables studied included age, gender, location and size of the tumor, extent of resection, disease-free interval, and morbidity and mortality. Statistical analyses were performed using the log-rank test and Kaplan-Meier estimates, with overall survival as the primary end point.
RESULTS: The study population consisted of 25 patients (13 males), with a median age of 55 years and a median follow-up of 29 (range, 1-151) months. The median time to first retroperitoneal recurrence was 23 (range, 3-72) months. Twenty patients underwent resection, whereas five patients were deemed unresectable at the time of operation. The median survival in patients who underwent resection patients was 31 months compared with 3 months in those patients who did not undergo resection (P = 0.0001). Analysis of the entire group demonstrated a disease-free interval of greater than 24 months to be a positive predictor of outcome (median survival, 30 vs. 48 months; P = 0.02). For patients undergoing resection, the presence of positive margins (P = 0.01) and tumor size >or=5 cm (P = 0.008) predicted a worse prognosis. In patients who underwent resection, the two-year and five-year overall survival rates were 60 and 15 percent, respectively.
CONCLUSIONS: Patients with isolated retroperitoneal recurrences of colorectal cancer generally have a poor prognosis. However, a longer disease-free interval, complete negative-margin resection, and smaller tumor size are associated with long-term survival in selected patients.

Entities:  

Mesh:

Year:  2002        PMID: 12072633     DOI: 10.1007/s10350-004-6300-3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  22 in total

1.  Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.

Authors:  Manabu Shimomura; Masazumi Okajima; Takao Hinoi; Hiroyuki Egi; Yuji Takakura; Yasuo Kawaguchi; Masakazu Tokunaga; Tomohiro Adachi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2012-03-10       Impact factor: 2.571

Review 2.  Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.

Authors:  Atsuya Takeda; Naoko Sanuki; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Rapid Development of Omentum Metastasis Following Stereotactic Body Radiotherapy (Sbrt) to Para-Aortic Lymph Nodes from Colon Cancer.

Authors:  Sudhamshi Toom; Yiqing Xu
Journal:  J Gastrointest Cancer       Date:  2018-06

4.  Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer.

Authors:  Mi-Sook Kim; Chul Koo Cho; Kwang Mo Yang; Dong Han Lee; Sun Mi Moon; Young Joo Shin
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

5.  A Curative-Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single-Institutional Experience.

Authors:  Benny Johnson; Zhaohui Jin; Michael G Haddock; Christopher L Hallemeier; James A Martenson; Rory L Smoot; David W Larson; Eric J Dozois; David M Nagorney; Axel Grothey
Journal:  Oncologist       Date:  2018-02-14

6.  Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.

Authors:  Nozomu Nakai; Tomohiro Yamaguchi; Yusuke Kinugasa; Akio Shiomi; Hiroyasu Kagawa; Yushi Yamakawa; Masakatsu Numata; Akinobu Furutani
Journal:  Int J Colorectal Dis       Date:  2017-04-05       Impact factor: 2.571

Review 7.  Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.

Authors:  Young Seok Seo; Mi-Sook Kim; Hyung-Jun Yoo; Won-Il Jang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.

Authors:  Ciro Franzese; Antonella Fogliata; Tiziana Comito; Angelo Tozzi; Cristina Iftode; Elena Clerici; Davide Franceschini; Pierina Navarria; Anna Maria Ascolese; Lucia Di Brina; Fiorenza De Rose; Giuseppe R D'Agostino; Luca Cozzi; Marta Scorsetti
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

9.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

Review 10.  [Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies].

Authors:  J R Siewert; F Lordick; K Ott; B L D M Brücher; R Rosenberg
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.